Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis

BMC Pulmonary Medicine

Volumn 11, Issue , 2011, Pages

  Laube, Beth L ^a   Sharpless, Gail ^a   Carson, Kathryn A ^a   Kelly, Amber ^a   Mogayzel Jr, Peter J ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SALBUTAMOL; SODIUM CHLORIDE; TECHNETIUM SULFUR COLLOID TC 99M;

AEROSOL; ARTICLE; BRONCHOSPASM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; CYSTIC FIBROSIS; DOUBLE BLIND PROCEDURE; DRUG DISTRIBUTION; DRUG TREATMENT FAILURE; FEMALE; HUMAN; MALE; MUCOCILIARY CLEARANCE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TIME; ADOLESCENT; ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; FORCED EXPIRATORY VOLUME; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; CHILD; CROSS-OVER STUDIES; CYSTIC FIBROSIS; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MUCOCILIARY CLEARANCE; RESPIRATORY FUNCTION TESTS; SALINE SOLUTION, HYPERTONIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80052574268     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-11-45     Document Type: Article

References (18)

1. Boucher RC. Evidence for airway surface dehydration as the initiating event in CF airway disease. J Internal Med 2007, 261:5-16. 10.1111/j.1365-2796.2006.01744.x, 17222164.
2. Rubin BK. Mucus, phlegm, and sputum in cystic fibrosis. Respir Care 2009, 54:726-732; discussion 732. 10.4187/002013209790983269, 19467160.
3. Robinson M, Regnis JA, Bailey DL, King M, Bautovich GJ, Bye PT. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Am J Respir Crit Care Med 1996, 153:1503-1509.
4. Robinson M, Hemming AL, Regnis JA, Wong AG, Bailey DL, Bautovich GJ, King M, Bye PT. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax 1997, 52:900-903. 10.1136/thx.52.10.900, 1758438, 9404379.
5. Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 2006, 354:241-250. 10.1056/NEJMoa043891, 16421365.
6. Flume PA, O'Sullivan BP, Robinson KA, Goss CH, Mogayzel PJ, Willey-Courand DB, Bujan J, Finder J, Lester M, Quittell L, Rosenblatt R, Vender RL, Hazle L, Sabadosa K, Marshall B. Cystic fibrosis pulmonary guidelines: Chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2007, 176:957-969. 10.1164/rccm.200705-664OC, 17761616.
7. Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006, 354:229-240. 10.1056/NEJMoa043900, 16421364.
8. Eng PA, Morton J, Douglass JA, Riedler J, Wilson J, Robertson CF. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Ped Pulmonol 1996, 21:77-83.
9. Cystic Fibrosis Foundation Patient Registr annual data report. 2008, Bethesda, Maryland, Cystic Fibrosis Foundation Patient Registr.
10. Mayer-Hamblett N, Aitken ML, Accurso FJ, Kronmal RA, Konstan MW, Burns JL, Sagel SD, Ramsey BW. Association between pulmonary function and sputum biomarkers in cystic fibrosis. Am J Respir Crit Care Med 2007, 175:822-828. 10.1164/rccm.200609-1354OC, 2720115, 17234902.
11. Suri R, Marshall LJ, Wallis C, Metcalfe C, Shute JK, Bush A. Safety and use of sputum induction in children with cystic fibrosis. Ped Pulmonol 2003, 35:309-313.
12. Laube BL, Norman PS, Wagner HN, Adams GK. The effect of aerosol distribution on airway responsiveness to inhaled methacholine in patients with asthma. J Allergy Clin Immunol 1992, 89:510-518. 10.1016/0091-6749(92)90317-U, 1740581.
13. Cleary JC, Karmazyn YJ, Mogayzel PJ, Laube BL. Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. Pulmonary Pharmacology & Therapeutics 2008, 21:105-11. 10.1016/j.pupt.2007.01.002, 21881146.
14. Mortensen J, Hansen A, Falk M, Nielsen IK, Groth S. Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis. Chest 1993, 103:805-811. 10.1378/chest.103.3.805, 8095449.
15. Mortensen J, Groth S, Lange P, Hermansen F. Effect of terbutaline on mucociliary clearance in asthmatic and healthy subjects after inhalation from a pressurized inhaler and a dry powder inhaler. Thorax. 1991, 46:817-823.
16. McShane D, Davies JC, Wodehouse T, Bush A, Geddes D, Alton EWFW. Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect. Eur Respir J 2004, (24):95-100.
17. Kellerman D, Mospan AR, Engels J, Schaberg A, Gorden J, Denufosol SL. A review of studies with inhaled P2Y2 agonists that led to Phase 3. Pulmonary Pharmacol & Therapeutics 2008, 21:600-607. 10.1016/j.pupt.2007.12.003, 21898334.
18. Amin R, Subbarao P, Jaber A, Balkovec S, Jensen R, Kerrigan S, Gustafsson P, Ratjen F. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax 2010, 65:379-383. 10.1136/thx.2009.125831, 20435858.